FINWIRES · TerminalLIVE
FINWIRES

中部電力、2025年の発電量下方修正へ。中東情勢の緊張がエネルギー需要に影響を与える可能性も。

By

-- 中部電力は火曜日、2025年通年の発電量が9.2テラワット時(TWh)となり、前年の9.7TWhから減少したと発表した。 水力発電量は前年の9.3TWhから8.8TWhに減少した一方、その他の再生可能エネルギー発電量は400GWhで横ばいだった。 エネルギー関連サービスを提供するミライズ事業部は、2025年に109.0TWhの電力を販売し、2024年の107.9TWhから増加した。しかし、燃料費調整費の減少により、営業収益は3.5%減の2兆8590億円(179億2000万ドル)となった。 送電網事業部は、2025年に中部地方で123.9TWhの電力需要を供給し、前年の124.5TWhから減少した。関連する営業収益も3.6%減の9,286億3,000万円となった。 「現時点では、中部地方の電力需要への影響は限定的です。しかし、中東情勢の緊張が高まり長期化すれば、原油をはじめとするエネルギー源の供給不安から、中部地方の電力需要に影響が出る可能性があります」と同社は述べた。 同社は、燃料価格や卸売電力市場価格の不確実性を理由に、2027年3月期決算の業績予想を公表しなかった。

Related Articles

Research

Research Alert: Sherwin-willams Q1 Eps Tops Expectations

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:SHW posted Q1 adjusted EPS of $2.35 versus $2.25 prior year, beating our $2.17 estimate and $2.27 consensus view. Net sales advanced 6.8% Y/Y to $5.67B, exceeding our 4.0% growth forecast, led by the Suvinil acquisition, favorable FX, and modest volume gains. The company demonstrated solid operational execution, with Paint Stores same-store sales improving to 2.4% from 1.2% in the prior year and Consumer Brands posting 19.2% growth, though North American DIY demand remained soft. Management maintained FY2026 guidance of low- to mid-single-digit sales growth with adjusted EPS projected at $11.50-$11.90, representing ~2.4% growth at the midpoint. Gross margin expanded 90bps to 49.1% on moderating raw material costs and improved pricing, though SG&A rose 9.8% as Suvinil integration costs pressured margins. The company also continued its shareholder return program in Q1, deploying $772.7M through dividends and share repurchases, despite acknowledging persistent macroeconomic uncertainty.

$SHW
Research

Research Alert: Ecolab Posts Solid Q1; Accelerated Growth; Near-term Margin Pressure Expected

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Ecolab reported Q1 sales of $4.1B (+10% Y/Y), $37M above consensus, with organic growth accelerating to +4% from +3% in Q4. Adjusted EPS of $1.70 (+13% Y/Y) met consensus, while operating margin expanded 70 bps to 16.7%, progressing toward the 20% target by 2027. Growth engines (20% of sales) showed strengthening momentum, with Global High-Tech delivering +25% organic growth from AI infrastructure and Life Sciences accelerating to +11% led by bioprocessing demand. Management maintained full-year EPS guidance of $8.43-$8.63 (+12% to +15%) but guided Q2 below estimates due to commodity cost pressures requiring energy surcharges. We view the High-Tech momentum as particularly significant given the multi-year AI data center runway, while the pending CoolIT acquisition reinforces ECL's end-to-end cooling capabilities. We see risk to 2H margin expansion if commodity costs remain elevated or if pricing implementation faces resistance, testing ECL's value proposition and customer relationships.

$ECL
Asia

China Resources Pharmaceutical Unit Sells 1.4 Billion Yuan Bonds

China Resources Pharmaceutical (HKG:3320) unit China Resources Pharmaceutical Commercial Group completed the issue of 1.4 billion yuan of 1.65% corporate bonds in China maturing in three years, according to a Tuesday Hong Kong bourse filing.The pharma firm intends to use proceeds for production expenditures, including the replenishment of working capital, repayment of debt, and project investments.

$HKG:3320